Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B

被引:12
作者
Zhou, Huanqin [2 ]
Wu, Xianguo [3 ]
Lu, Xingguo [4 ]
Chen, Gang [2 ]
Ye, Xiongwei [2 ]
Huang, Jian [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Hosp, Dept Clin Lab, Hangzhou 310013, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Clin Lab Diag, Hangzhou 310009, Zhejiang, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Haematol, Hangzhou 310009, Zhejiang, Peoples R China
关键词
Hepatitis B; Urokinase-type plasminogen activator; Urokinase-type plasminogen activator receptor; Plasma; GROWTH; CARCINOMA;
D O I
10.1016/j.thromres.2008.06.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Urokinase-type plasminogen activator (uPA) and urokinase-type plasminogen activator receptor (uPAR) are known to be important factors in the pathogenesis of tumors and certain non-viral inflammatory diseases. However, their role in infectious virus diseases such as hepatitis B has been less well studied. This study aimed to test the hypothesis that the abnormalities of fibrinolysis and degradation of extracellular matrix mediated by uPA and uPAR are directly related to the inflammatory damage to liver cells caused by the hepatitis B virus. We therefore analyzed their role and clinicopathological significance in patients with acute or chronic hepatitis B. Materials and methods: Eighty patients with acute or chronic hepatitis B, together with 30 healthy controls, were enrolled. uPA and uPAR in plasma were detected by commercial enzyme-linked immunosorbent assay (ELISA) kits. Results: The levels of uPA and uPAR in patients with acute or chronic hepatitis B significantly exceeded those in healthy controls (p<0.05). Patients with severe chronic hepatitis B had significantly higher levels of uPA and uPAR than those with moderate and mild chronic disease (p<0.05) and those with acute hepatitis B (p<0.05). Moreover, the plasma uPA and uPAR markedly increased in the acute stage (p<0.05) and dramatically decreased in the remission stage (p<0.05), but in all stages levels exceeded those in healthy subjects (p<0.05). In addition, the concentration of plasma uPAR was positively correlated with prothrombin (PT) (r=0.605, p<0.01) and total bilirubin (TBIL) (r=0.649, p<0.01). Conclusions: It is suggested that the plasma levels of uPA and uPAR are closely related to the degree and period of inflammation in patients with acute or chronic hepatitis B, and that uPA and uPAR might be important indicators for disease progression. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:537 / 542
页数:6
相关论文
共 23 条
[1]  
[Anonymous], 2005, Chin Med J (Engl), V120, P2159
[2]   Interleukin-6 and cyclic AMP stimulate release of cathepsin B in human osteoblasts [J].
Chae, Han-Jung ;
Ha, Ki-Chan ;
Lee, Geun-Youn ;
Yang, Sun-Kyung ;
Yun, Ki-Jung ;
Kim, Eun-Cheol ;
Kim, Sun-Hee ;
Chae, Soo-Wan ;
Kim, Hyung-Ryong .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2007, 29 (02) :155-172
[3]   Evaluation of nuclear factor-κB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma [J].
Chan, CF ;
Yau, TO ;
Jin, DY ;
Wong, CM ;
Fan, ST ;
Ng, IOL .
CLINICAL CANCER RESEARCH, 2004, 10 (12) :4140-4149
[4]  
CHIEN TT, 1989, THROMB HAEMOSTASIS, V62, P651
[5]   ENHANCEMENT OF THE ENZYMATIC-ACTIVITY OF SINGLE-CHAIN UROKINASE PLASMINOGEN-ACTIVATOR BY SOLUBLE UROKINASE RECEPTOR [J].
HIGAZI, AA ;
COHEN, RL ;
HENKIN, J ;
KNISS, D ;
SCHWARTZ, BS ;
CINES, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) :17375-17380
[6]   Inhibition of urokinase plasminogen activator with a novel enzyme inhibitor, wxc-340, ameliorates endotoxin and surgery-accelerated growth of murine metastases [J].
Killeen, S. D. ;
Andrews, E. J. ;
Wang, J. H. ;
Wu, T. ;
Schmalix, W. ;
Muehlenweg, B. ;
Redmond, H. P. .
BRITISH JOURNAL OF CANCER, 2007, 96 (02) :262-268
[7]   Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87) [J].
Krüger, A ;
Soeltl, R ;
Lutz, V ;
Wilhelm, OG ;
Magdolen, V ;
Rojo, EE ;
Hantzopoulos, PA ;
Graeff, H ;
Gänsbacher, B ;
Schmitt, M .
CANCER GENE THERAPY, 2000, 7 (02) :292-299
[8]   MECHANISMS OF PHYSIOLOGICAL FIBRINOLYSIS [J].
LIJNEN, HR ;
COLLEN, D .
BAILLIERES CLINICAL HAEMATOLOGY, 1995, 8 (02) :277-290
[9]  
LU XL, 2005, WORLD CHIN J DIGESTO, V13, P803
[10]   Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction [J].
May, AE ;
Schmidt, R ;
Kanse, SM ;
Chavakis, T ;
Stephens, RW ;
Schömig, A ;
Preissner, KT ;
Neumann, FJ .
BLOOD, 2002, 100 (10) :3611-3617